What is the current valuation of the Agrigenomics Market as of 2024?

The Agrigenomics Market was valued at 7.76 USD Billion in 2024. Read More

What is the projected market size for the Agrigenomics Market in 2035?

The market is projected to reach 16.19 USD Billion by 2035. Read More

What is the expected CAGR for the Agrigenomics Market during the forecast period 2025 - 2035?

The expected CAGR for the Agrigenomics Market during 2025 - 2035 is 6.91%. Read More

Which companies are considered key players in the Agrigenomics Market?

Key players include BASF SE, Syngenta AG, Corteva Agriscience, Bayer AG, and Monsanto Company. Read More

What are the main segments of the Agrigenomics Market?

The main segments include Genomic Technologies, Application Areas, End Users, Service Types, and Project Types. Read More

How much is the Genomic Technologies segment projected to grow by 2035?

The Genomic Technologies segment is projected to grow from 5.5 USD Billion in 2024 to an estimated value of 10.5 USD Billion by 2035. Read More

What is the projected growth for the Crop Improvement application area by 2035?

The Crop Improvement application area is expected to increase from 5.5 USD Billion in 2024 to approximately 10.5 USD Billion by 2035. Read More

What is the anticipated growth for the Agricultural Corporations end user segment by 2035?

The Agricultural Corporations segment is projected to grow from 5.8 USD Billion in 2024 to around 10.4 USD Billion by 2035. Read More

What is the expected growth for Research Projects in the Agrigenomics Market by 2035?

Research Projects are anticipated to grow from 5.5 USD Billion in 2024 to an estimated 11.5 USD Billion by 2035. Read More

Agrigenomics Market

Q: What services are included in the Service Type segment of the Agrigenomics Market?

The Service Type segment includes Genome Mapping Services, Data Analysis Services, Consulting Services, and Sample Preparation Services. Read More

ID: MRFR/LS/29511-HCR

128 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Agrigenomics Market Research Report By Genomic Technologies (Next-Generation Sequencing, Polymerase Chain Reaction, Genotyping, Gene Editing), By Application Areas (Crop Improvement, Livestock Breeding, Plant Pathology, Environmental Sustainability), By End User (Research Institutes, Agricultural Corporations, Government Agencies, Biotechnology Firms), By Service Type (Genome Mapping Services, Data Analysis Services, Consulting Services, Sample Preparation Services), By Project Type (Research Projects, Commercial Projects, Collaborative Projects) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Genomic Technologies (USD Billion)
  1. 4.1.1 Next-Generation Sequencing
  2. 4.1.2 Polymerase Chain Reaction
  3. 4.1.3 Genotyping
  4. 4.1.4 Gene Editing
2. 4.2 Healthcare, BY Application Areas (USD Billion)
  1. 4.2.1 Crop Improvement
  2. 4.2.2 Livestock Breeding
  3. 4.2.3 Plant Pathology
  4. 4.2.4 Environmental Sustainability
3. 4.3 Healthcare, BY End User (USD Billion)
  1. 4.3.1 Research Institutes
  2. 4.3.2 Agricultural Corporations
  3. 4.3.3 Government Agencies
  4. 4.3.4 Biotechnology Firms
4. 4.4 Healthcare, BY Service Type (USD Billion)
  1. 4.4.1 Genome Mapping Services
  2. 4.4.2 Data Analysis Services
  3. 4.4.3 Consulting Services
  4. 4.4.4 Sample Preparation Services
5. 4.5 Healthcare, BY Project Type (USD Billion)
  1. 4.5.1 Research Projects
  2. 4.5.2 Commercial Projects
  3. 4.5.3 Collaborative Projects
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 BASF SE (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Syngenta AG (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Corteva Agriscience (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bayer AG (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Monsanto Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 DuPont de Nemours, Inc. (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Illumina, Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Agilent Technologies, Inc. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 KWS SAAT SE (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
  10. 5.2.10 Genus plc (GB)
    1. 5.2.10.1 Financial Overview
    2. 5.2.10.2 Products Offered
    3. 5.2.10.3 Key Developments
    4. 5.2.10.4 SWOT Analysis
    5. 5.2.10.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
4. 6.4 US MARKET ANALYSIS BY APPLICATION AREAS
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 US MARKET ANALYSIS BY SERVICE TYPE
7. 6.7 US MARKET ANALYSIS BY PROJECT TYPE
8. 6.8 CANADA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
9. 6.9 CANADA MARKET ANALYSIS BY APPLICATION AREAS
10. 6.10 CANADA MARKET ANALYSIS BY END USER
11. 6.11 CANADA MARKET ANALYSIS BY SERVICE TYPE
12. 6.12 CANADA MARKET ANALYSIS BY PROJECT TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
15. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION AREAS
16. 6.16 GERMANY MARKET ANALYSIS BY END USER
17. 6.17 GERMANY MARKET ANALYSIS BY SERVICE TYPE
18. 6.18 GERMANY MARKET ANALYSIS BY PROJECT TYPE
19. 6.19 UK MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
20. 6.20 UK MARKET ANALYSIS BY APPLICATION AREAS
21. 6.21 UK MARKET ANALYSIS BY END USER
22. 6.22 UK MARKET ANALYSIS BY SERVICE TYPE
23. 6.23 UK MARKET ANALYSIS BY PROJECT TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
25. 6.25 FRANCE MARKET ANALYSIS BY APPLICATION AREAS
26. 6.26 FRANCE MARKET ANALYSIS BY END USER
27. 6.27 FRANCE MARKET ANALYSIS BY SERVICE TYPE
28. 6.28 FRANCE MARKET ANALYSIS BY PROJECT TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
30. 6.30 RUSSIA MARKET ANALYSIS BY APPLICATION AREAS
31. 6.31 RUSSIA MARKET ANALYSIS BY END USER
32. 6.32 RUSSIA MARKET ANALYSIS BY SERVICE TYPE
33. 6.33 RUSSIA MARKET ANALYSIS BY PROJECT TYPE
34. 6.34 ITALY MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
35. 6.35 ITALY MARKET ANALYSIS BY APPLICATION AREAS
36. 6.36 ITALY MARKET ANALYSIS BY END USER
37. 6.37 ITALY MARKET ANALYSIS BY SERVICE TYPE
38. 6.38 ITALY MARKET ANALYSIS BY PROJECT TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
40. 6.40 SPAIN MARKET ANALYSIS BY APPLICATION AREAS
41. 6.41 SPAIN MARKET ANALYSIS BY END USER
42. 6.42 SPAIN MARKET ANALYSIS BY SERVICE TYPE
43. 6.43 SPAIN MARKET ANALYSIS BY PROJECT TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION AREAS
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY END USER
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY SERVICE TYPE
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY PROJECT TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
51. 6.51 CHINA MARKET ANALYSIS BY APPLICATION AREAS
52. 6.52 CHINA MARKET ANALYSIS BY END USER
53. 6.53 CHINA MARKET ANALYSIS BY SERVICE TYPE
54. 6.54 CHINA MARKET ANALYSIS BY PROJECT TYPE
55. 6.55 INDIA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
56. 6.56 INDIA MARKET ANALYSIS BY APPLICATION AREAS
57. 6.57 INDIA MARKET ANALYSIS BY END USER
58. 6.58 INDIA MARKET ANALYSIS BY SERVICE TYPE
59. 6.59 INDIA MARKET ANALYSIS BY PROJECT TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
61. 6.61 JAPAN MARKET ANALYSIS BY APPLICATION AREAS
62. 6.62 JAPAN MARKET ANALYSIS BY END USER
63. 6.63 JAPAN MARKET ANALYSIS BY SERVICE TYPE
64. 6.64 JAPAN MARKET ANALYSIS BY PROJECT TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION AREAS
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY END USER
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY PROJECT TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
71. 6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION AREAS
72. 6.72 MALAYSIA MARKET ANALYSIS BY END USER
73. 6.73 MALAYSIA MARKET ANALYSIS BY SERVICE TYPE
74. 6.74 MALAYSIA MARKET ANALYSIS BY PROJECT TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
76. 6.76 THAILAND MARKET ANALYSIS BY APPLICATION AREAS
77. 6.77 THAILAND MARKET ANALYSIS BY END USER
78. 6.78 THAILAND MARKET ANALYSIS BY SERVICE TYPE
79. 6.79 THAILAND MARKET ANALYSIS BY PROJECT TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
81. 6.81 INDONESIA MARKET ANALYSIS BY APPLICATION AREAS
82. 6.82 INDONESIA MARKET ANALYSIS BY END USER
83. 6.83 INDONESIA MARKET ANALYSIS BY SERVICE TYPE
84. 6.84 INDONESIA MARKET ANALYSIS BY PROJECT TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
86. 6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION AREAS
87. 6.87 REST OF APAC MARKET ANALYSIS BY END USER
88. 6.88 REST OF APAC MARKET ANALYSIS BY SERVICE TYPE
89. 6.89 REST OF APAC MARKET ANALYSIS BY PROJECT TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
92. 6.92 BRAZIL MARKET ANALYSIS BY APPLICATION AREAS
93. 6.93 BRAZIL MARKET ANALYSIS BY END USER
94. 6.94 BRAZIL MARKET ANALYSIS BY SERVICE TYPE
95. 6.95 BRAZIL MARKET ANALYSIS BY PROJECT TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
97. 6.97 MEXICO MARKET ANALYSIS BY APPLICATION AREAS
98. 6.98 MEXICO MARKET ANALYSIS BY END USER
99. 6.99 MEXICO MARKET ANALYSIS BY SERVICE TYPE
100. 6.100 MEXICO MARKET ANALYSIS BY PROJECT TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
102. 6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION AREAS
103. 6.103 ARGENTINA MARKET ANALYSIS BY END USER
104. 6.104 ARGENTINA MARKET ANALYSIS BY SERVICE TYPE
105. 6.105 ARGENTINA MARKET ANALYSIS BY PROJECT TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION AREAS
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROJECT TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION AREAS
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY END USER
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY SERVICE TYPE
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY PROJECT TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION AREAS
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY END USER
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY SERVICE TYPE
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY PROJECT TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY GENOMIC TECHNOLOGIES
123. 6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION AREAS
124. 6.124 REST OF MEA MARKET ANALYSIS BY END USER
125. 6.125 REST OF MEA MARKET ANALYSIS BY SERVICE TYPE
126. 6.126 REST OF MEA MARKET ANALYSIS BY PROJECT TYPE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY GENOMIC TECHNOLOGIES, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY GENOMIC TECHNOLOGIES, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY APPLICATION AREAS, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY APPLICATION AREAS, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY END USER, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY PROJECT TYPE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY PROJECT TYPE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.2.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.2.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.3.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.3.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.3.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.4.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.4.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.4.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.5.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.5.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.5.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.6.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.6.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.6.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.7.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.7.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.7.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.8.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.8.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.8.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.9.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.9.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.9.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.10.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.10.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.10.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.11.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.11.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.11.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.12.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.12.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.12.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.13.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.13.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.13.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.14.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.14.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.14.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.15.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.15.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.15.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.16.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.16.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.16.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.17.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.17.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.17.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.18.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.18.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.18.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.19.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.19.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.19.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.20.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.20.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.20.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.21.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.21.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.21.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.22.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.22.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.22.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.23.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.23.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.23.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.24.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.24.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.24.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.25.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.25.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.25.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.26.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.26.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.26.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.27.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.27.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.27.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.28.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.28.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.28.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.29.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.29.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.29.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY GENOMIC TECHNOLOGIES, 2025-2035 (USD Billion)
  2. 7.30.2 BY APPLICATION AREAS, 2025-2035 (USD Billion)
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.30.4 BY SERVICE TYPE, 2025-2035 (USD Billion)
  5. 7.30.5 BY PROJECT TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Genomic Technologies (USD Billion, 2025-2035)

Next-Generation Sequencing
Polymerase Chain Reaction
Genotyping
Gene Editing

Healthcare By Application Areas (USD Billion, 2025-2035)

Crop Improvement
Livestock Breeding
Plant Pathology
Environmental Sustainability

Healthcare By End User (USD Billion, 2025-2035)

Research Institutes
Agricultural Corporations
Government Agencies
Biotechnology Firms

Healthcare By Service Type (USD Billion, 2025-2035)

Genome Mapping Services
Data Analysis Services
Consulting Services
Sample Preparation Services

Healthcare By Project Type (USD Billion, 2025-2035)

Research Projects
Commercial Projects
Collaborative Projects

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓